Access to biologicals in Crohn’s disease in ten European countries

doi:10.3748/wjg.v23.i34.6294

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 34

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9145)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

696

WORD

303

HTML

5123

Figures (1-1)

187

Tables (1-5)

219

Sum=6528

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1013

Download

1604

Sum=2617

Sep 14, 2017 (publication date) through Sep 19, 2024

Times Cited of This Article

Times Cited (34)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Sep 14, 2017; 23(34): 6294-6305
Published online Sep 14, 2017. doi: 10.3748/wjg.v23.i34.6294

Open in New Tab Full Size Figure Download Figure

Figure 1 Associations between availability, affordability, gross domestic product per capita and the uptake of biosimilars. Cz: The Czech Republic; Fr: France; D: Germany; Hu: Hungary; Lv: Latvia; Pl: Poland; Ro: Romania; Sk: Slovakia; Es: Spain; Se: Sweden; Prevalence: Patients on biologicals per 100000 population. GDP: Gross domestic product.

Citation: Péntek M, Lakatos PL, Oorsprong T, Gulácsi L, Pavlova M, Groot W, Rencz F, Brodszky V, Baji P, Crohn’s Disease Research Group. Access to biologicals in Crohn’s disease in ten European countries. World J Gastroenterol 2017; 23(34): 6294-6305
URL: https://www.wjgnet.com/1007-9327/full/v23/i34/6294.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i34.6294